SHL Telemedicine Appoints New Chairman
Ticker: SHMLF · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment
TL;DR
SHL Telemedicine has a new Chairman, Dr. Itamar Offer, effective immediately.
AI Summary
SHL Telemedicine Ltd. announced on September 3, 2024, the immediate appointment of Dr. Itamar Offer as the new Chairman of the Board of Directors. This information was disclosed in a press release furnished as part of a Form 6-K filing with the SEC.
Why It Matters
A change in board leadership can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a board appointment and does not contain significant financial or operational news.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Company making the announcement
- Dr. Itamar Offer (person) — Newly appointed Chairman of the Board
- September 3, 2024 (date) — Date of the press release and announcement
FAQ
Who has been appointed as the new Chairman of the Board of Directors for SHL Telemedicine Ltd.?
Dr. Itamar Offer has been appointed as the new Chairman of the Board of Directors for SHL Telemedicine Ltd.
When was the appointment of the new Chairman effective?
The appointment of Dr. Itamar Offer as Chairman was effective immediately as of September 3, 2024.
What type of filing is this with the SEC?
This is a Form 6-K filing, which is a Report of Foreign Private Issuer.
What is the principal executive office address of SHL Telemedicine Ltd.?
The principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F or Form 40-F?
SHL Telemedicine Ltd. files annual reports under Form 20-F.
Filing Stats: 228 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-09-03 09:04:43
Filing Documents
- zk2431980.htm (6-K) — 9KB
- exhibit_99-1.htm (EX-99.1) — 10KB
- image2.jpg (GRAPHIC) — 430KB
- image3.jpg (GRAPHIC) — 646KB
- image4.jpg (GRAPHIC) — 20KB
- image00005.jpg (GRAPHIC) — 4KB
- image00007.jpg (GRAPHIC) — 3KB
- 0001178913-24-002932.txt ( ) — 1541KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On September 3, 2024, SHL Telemedicine Ltd. (the " Company ") issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release, the Company announced that it has appointed Dr. Itamar Offer to serve as the Company's new Chairman of the Board of Directors, effective immediately. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546). Exhibit Description 99.1 Press release, dated September 3, 2024, issued by the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer September 3, 2024